Nootropil: Advanced Cognitive Support for Neurological Health
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $56.76 (0%) | 🛒 Add to cart |
| 90 | $0.92 | $85.14 $82.56 (3%) | 🛒 Add to cart |
| 120 | $0.90 | $113.52 $107.50 (5%) | 🛒 Add to cart |
| 180 | $0.88 | $170.28 $158.24 (7%) | 🛒 Add to cart |
| 270 | $0.87 | $255.42 $234.78 (8%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $340.56 $312.18 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil is a high-purity pharmaceutical-grade nootropic agent, classified as a racetam compound, specifically indicated for the management of cognitive deficits. Its primary mechanism of action involves modulation of central neurotransmitter systems, enhancing neuroplasticity and supporting metabolic processes within cerebral tissues. Clinically, it is utilized to support cognitive function in a range of neurological conditions, offering a well-tolerated profile for appropriate patient populations under medical supervision.
Features
- Active ingredient: Piracetam 800mg or 1200mg per tablet
- Pharmaceutical formulation: Film-coated tablets for optimized bioavailability
- Prescription-only medication in most jurisdictions
- Manufactured under strict GMP (Good Manufacturing Practice) standards
- Chemical structure: 2-oxo-1-pyrrolidine acetamide
- Half-life: Approximately 4–5 hours in adults
- Excretion: Primarily renal, unchanged
Benefits
- Supports cognitive function including memory, learning, and concentration
- May aid in the recovery and rehabilitation process following cerebral incidents
- Assists in the management of cortical myoclonus as an adjunct therapy
- Can contribute to improved verbal fluency in age-related cognitive decline
- Provides neuroprotective benefits by supporting neuronal membrane fluidity
- Used adjunctively in dyslexia and sickle cell anemia-related complications in some regions
Common use
Nootropil is primarily prescribed for cognitive enhancement in patients experiencing mild to moderate cognitive impairment, often associated with aging or neurological conditions. It is also used in the management of myoclonus of cortical origin. Off-label, it is sometimes utilized in supportive therapy for vertigo and dyslexia, though such use should be carefully evaluated by a healthcare provider. It is not intended as a general wellness supplement and requires diagnostic justification for prescription.
Dosage and direction
Dosage must be individualized based on patient condition, renal function, and clinical response. For cognitive disorders in adults, the typical initial dosage is 2400–4800 mg per day, divided into 2–3 doses. This may be adjusted up to a maximum of 9600 mg daily in divided doses, depending on tolerance and efficacy. For cortical myoclonus, dosing often starts at 7200 mg/day, increasing by 4800 mg every 3–4 days up to 24 g/day, divided into doses. Administration should be with or after food to minimize potential gastrointestinal discomfort. Dosage must be reduced in patients with renal impairment.
Precautions
Patients with a history of haemorrhagic diathesis or those undergoing major surgery should use Nootropil with caution due to its effects on platelet aggregation. Renal function should be assessed before and during treatment, especially in elderly patients. Use during pregnancy or lactation is not recommended unless clearly needed and under strict medical supervision. Caution is advised when operating machinery or driving until the individual response is known. Discontinuation should be gradual to avoid withdrawal effects in long-term users.
Contraindications
Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It should not be used in patients with severe renal impairment (creatinine clearance <20 mL/min) or end-stage renal disease. It is also contraindicated in those with Huntington’s chorea due to risk of exacerbating symptoms. Use is not recommended in patients with cerebral haemorrhage or acute stroke.
Possible side effects
Most side effects are dose-dependent and often transient. Commonly reported adverse reactions include nervousness, weight gain, somnolence, depression, and asthenia. Gastrointestinal effects such as nausea, vomiting, diarrhoea, and abdominal pain may occur. Less frequently, patients may experience hyperkinesia, ataxia, confusion, or dizziness. Rash and pruritus have been reported in some cases. Serious side effects are rare but may include severe hypersensitivity reactions or thrombophlebitis with intravenous use (though tablets are standard).
Drug interaction
Nootropil may potentiate the effects of central nervous system stimulants and antiplatelet/anticoagulant drugs (e.g., warfarin, aspirin), increasing the risk of bleeding. Concurrent use with thyroid hormone extracts may increase restlessness and irritability. It might also interact with drugs that affect renal function. Always inform the prescribing physician of all concomitant medications, including over-the-counter drugs and herbal supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent blood levels is important for efficacy, so adherence to the prescribed regimen is advised.
Overdose
Symptoms of overdose may include diarrhoea, abdominal pain, and pronounced lethargy. In severe cases, haemorrhagic complications or pronounced CNS depression could occur. There is no specific antidote; treatment is symptomatic and supportive. Gastric lavage may be considered if ingestion was recent. Haemodialysis may be effective due to the drug’s low protein binding and renal excretion.
Storage
Store in the original container at room temperature (15–30°C), protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Avoid storing in bathrooms or damp areas to prevent degradation of the film coating.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing your treatment plan. Do not disregard professional medical advice or delay seeking it based on content provided here. Individual responses to medication may vary.
Reviews
Clinical studies and patient reports generally reflect positive outcomes in cognitive support, particularly in vascular dementia and post-stroke recovery. Many users note gradual improvement in memory recall and mental clarity over several weeks of use. Some reports mention gastrointestinal discomfort as an initial hurdle. Overall, it is regarded as a valuable adjunct in neurological therapeutic regimens when used appropriately under medical guidance.